| 产品描述: | hDHODH-IN-1 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor. hDHODH-IN-1 has anti-inflammatory effect |
| 靶点: |
Dehydrogenase |
| 体外研究: |
Human dihydroorotate dehydrogenase (hDHODH) is a class-2 dihydroorotate dehydrogenase. Because DHODH is required to ensure proliferating-cell viability, inhibitors have been developed to eliminate human DHODH (hDHODH) activity, which is associated with cancers, multiple sclerosis, and autoimmune and inflammatory diseases. |
| 参考文献: |
1. Shih KC, et al. Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors. PLoS One. 2014 Feb 4;9(2):e87960. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 备注: |
hDHODH-IN-1 是一种人二氢乳清酸脱氢酶 (hDHODH) 抑制剂, 具有抗炎作用。 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.593 ml |
17.966 ml |
35.931 ml |
| 5 mM |
0.719 ml |
3.593 ml |
7.186 ml |
| 10 mM |
0.359 ml |
1.797 ml |
3.593 ml |
| 50 mM |
0.072 ml |
0.359 ml |
0.719 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |